US FDA approves BioMarin’s gene therapy for hemophilia A
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia…
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia…
By Lucia Mutikani WASHINGTON (Reuters) – The number of Americans filing new claims for unemployment benefits fell last week by…
WASHINGTON (Reuters) – A Chinese spy balloon that flew over the United States earlier this year before being shot down…
By Niket Nishant and Krystal Hu (Reuters) -Inflection AI, a startup backed by several Silicon Valley heavyweights, said on Thursday…